Trial Profile
A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Prostate cancer vaccine (Primary) ; Aldesleukin; Granulocyte-macrophage colony-stimulating factors
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 16 Aug 2006 Status change
- 12 Oct 2005 New trial record.